Intellia Therapeutics to Present at October Healthcare

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
34
Intellia Therapeutics to Present at October Healthcare Investor Conferences

CAMBRIDGE, Mass., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA ), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR/Cas9 technology, will present at the following upcoming healthcare conferences in October:

Tuesday, October 10, 2017 Chardan Gene Therapy Conference Who: Tom Barnes, Ph.D., Senior Vice President, Innovation Sciences & eXtellia Location: New York, New York Presentation Time: 2:45 pm EDT

Thursday, October 12, 2017 Jefferies Gene Therapy and Editing Summit Who: Nessan Bermingham, Ph.D., President, Chief Executive Officer and Founder Location: New York, New York Presentation Time: 1:40 pm EDT

A live webcast of Intellia’s presentations will be accessible through the Events and Presentations page of the Investor Relations section of the company’s website at www.intelliatx.com. To access the webcasts, please log on to the Intellia website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Intellia’s website for 14 days following each conference.

About Intellia Therapeutics

Intellia Therapeutics is a leading genome editing company focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. Our combination of deep scientific, technical and clinical development experience, along with our leading intellectual property portfolio, puts us in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. Learn more about Intellia Therapeutics and CRISPR/Cas9 at intelliatx.com ; Follow us on Twitter @intelliatweets.

Intellia Contacts:

Media Contact:                                                            Jennifer Mound Smoter                                              Senior Vice President, External Affairs                      & Communications                                                     +1 857-706-1071                                                        jenn.smoter@intelliatx.com

Investor Contact: Lindsey Trickett Vice President, Investor Relations +1 857-285-6211 lindsey.trickett@intelliatx.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 9

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 5

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 3

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 3

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 3

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 4

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 6

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading

Top 5 Most Recently Viewed Articles

Peijia Medical Advances Global Reach with GeminiOne TEER Device

Updated Category News Views 157

Peijia Medical's CE Mark Application Submission Peijia Medical Limited (HKEX: 9996) has taken a significant step in its mission to globalize its medical innovations by formally submitting the CE Mark registration application for its innovative GeminiOne Transcatheter Edge-to-Edge Repair (TEER) System. This device is engineered for treating mitral regurgitation, showcasing...

Continue Reading
Market Insights: UBS Picks for Future Growth

Updated Category News Views 248

Market Trends and Forecasts As summer comes to an end, those keeping an eye on the market are noticing a mix of resilience and challenges within the financial landscape. The S&P 500 has shown impressive growth, boasting an 18% gain year-to-date and approaching its all-time high. However, with economic uncertainties and upcoming elections on the horizon, investors are...

Continue Reading
Future of Renewable Energy and AI Data Centers: Insights from MUFG

Updated Category News Views 292

Understanding the Shift Towards Renewable Energy and AI In an evolving energy landscape, MUFG Americas CEO Kevin Cronin highlights the ongoing shift towards renewable energy, emphasizing that this trend is unlikely to wane despite political changes. The current push towards sustainability remains robust, and technologies around artificial intelligence (AI) are acting as a...

Continue Reading
Silicom Ltd's Q4 2024 Financial Performance Overview

Updated Category News Views 125

Overview of Silicom Ltd. Financial Results Silicom Ltd. (NASDAQ: SILC), a prominent leader in networking and data infrastructure solutions, has showcased its performance for the fourth quarter of the fiscal year. The company has had a challenging yet progressive quarter as detailed in their latest financial release. Fourth Quarter Performance Highlights During the fourth...

Continue Reading
Forian Expands Its Horizons with Kyber Data Science Buy

Updated Category News Views 96

Forian Inc. Enhances Data Analytics Through Strategic Acquisition Forian Inc. (NASDAQ: FORA), an innovator in data science-driven information and analytics for the healthcare and life sciences sectors, is making waves in the analytics landscape. The recent acquisition of Kyber Data Science LLC marks a significant advancement, aligning the company with a trusted provider...

Continue Reading